Author:
van Gelder C. M.,van Capelle C. I.,Ebbink B. J.,Moor-van Nugteren I.,van den Hout J. M. P.,Hakkesteegt M. M.,van Doorn P. A.,de Coo I. F. M.,Reuser A. J. J.,de Gier H. H. W.,van der Ploeg A. T.
Subject
Genetics (clinical),Genetics
Reference36 articles.
1. Amalfitano A, Bengur AR, Morse RP et al. (2001) Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med 3:132–138
2. Begley DJ, Pontikis CC, Scarpa M (2008) Lysosomal storage diseases and the blood-brain barrier. Curr Pharm Des 14:1566–1580
3. Bijvoet AG, Van Hirtum H, Kroos MA et al. (1999) Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II. Hum Mol Genet 8:2145–2153
4. Chakrapani A, Vellodi A, Robinson P, Jones S, Wraith JE (2010) Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience. J Inherit Metab Dis 33:747–750
5. Darley FL, Aronson AE, Brown JR (1969a) Clusters of deviant speech dimensions in the dysarthrias. J Speech Hear Res 12:462–496
Cited by
78 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献